Health disparities in the risk of severe acidosis: real-world evidence from the All of Us cohort is a dataset published in Journal of the American Medical Informatics Association (2024). On theSindex it has a DataRank of 0.137, placing it in the top 70.6% of the data-sharing corpus. It has been cited 1 time, with 1 citing works in its 1-hop citation network. Its calibrated FAIR score is 19/100.
Ranks in the top 71% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
Full FAIR picture · advisory
The headline score is computed from the scored criteria — the fact-shaped checks (a repository, an accession, a licence) that two independent models agree on. The advisory criteria below are real FAIR guidance but rest on judgment calls that models read differently, so they inform without moving the number.
“All data and codes are available at All of Us Research Workbench under the workspace 'Acidosis Risk Health Disparities' for users who are authorized to access All of Us Controlled Tier Data v7. Codes for reproducing the analysis are also available at https://github.com/Su-informatics-lab/aou_acidosis.”— not found in the paper; verdict downgraded
No persistent identifier (DOI, Handle, ARK, repository accession) is given for the dataset; the only location is a workspace name.
RDA-F1-01D — FAIR Data Maturity Model: 'Data is identified by a persistent identifier' (priorit · RDA-F1-02D — FAIR Data Maturity Model: 'Data is identified by a globally unique identifier' · FsF-F1-02D — F-UJI/FAIRsFAIR: 'Data is assigned a persistent identifier'
“All data and codes are available at All of Us Research Workbench under the workspace 'Acidosis Risk Health Disparities' for users who are authorized to access All of Us Controlled Tier Data v7.”— not found in the paper; verdict downgraded
All of Us Research Workbench is a platform for accessing the controlled dataset, but it is not a standard named repository like GEO or Zenodo. [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (3/5 passes agreed)]
RDA-F4-01M — FAIR Data Maturity Model: metadata is offered so it can be harvested and indexed ( · NIH DMS Policy Element 4 (NOT-OD-21-014) — name the repository where data will be archived · NSTC Desirable Characteristics of Data Repositories (2022) — 'Long-Term Sustainability', 'Reten
No identifier for the dataset appears in the reference list or body text; the data availability statement mentions a workspace name but not as a reference list entry.
FORCE11 Joint Declaration of Data Citation Principles (2014) — data should be cited as a first- · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes · FsF-F3-01M — F-UJI: 'Metadata includes the identifier of the data it describes'
Advisory · not in the published score
“All data and codes are available at All of Us Research Workbench under the workspace 'Acidosis Risk Health Disparities' for users who are authorized to access All of Us Controlled Tier Data v7. Codes for reproducing the analysis are also available at https://github.com/Su-informatics-lab/aou_acidosis.”— not found in the paper; verdict downgraded
The statement points to a repository (All of Us Research Workbench) but does not carry an accession, DOI, or persistent link; it is a repository location without a standard identifier. [downgraded to 'no' — no verifiable quote from the paper]
Colavizza, Hrynaszkiewicz, Staden, Whitaker & McGillivray (2020), 'The citation advantage of li · Springer Nature research data policy — Data Availability Statements: standard statement templat · RDA-F3-01M — metadata clearly and explicitly includes the identifier of the data it describes
“Specifically, we use the Curated Data Repository version 7 C2022Q4R9, established in April 2023, with a cutoff date of July 1, 2022. The conditions, drug exposures, labs and measurements, and visits in the EHR domains, the Basics in the Survey domain, and the whole genome sequencing (WGS) data in the Genomics domain are used.”— not found in the paper; verdict downgraded
The dataset content is described in running prose, not in an itemised inventory (section, table, or list). [downgraded to 'no' — no verifiable quote from the paper] [majority verdict 'no' (4/5 passes agreed)]
RDA-F2-01M — 'Rich metadata is provided to allow discovery' (priority Essential) · FsF-F2-01M — F-UJI: 'Metadata includes descriptive core elements to support data findability' · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data'
“for users who are authorized to access All of Us Controlled Tier Data v7”
Access requires authorization, which is a precondition; thus the data are not unconditionally open.
RDA-A1.1-01D — 'Data is accessible through a free access protocol' · FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · NSTC Desirable Characteristics of Data Repositories (2022) — 'Free and Easy Access'
Advisory · not in the published score
“All of Us Controlled Tier Data v7”
The paper labels the data as 'All of Us Controlled Tier Data', which is an explicit access-level label. [majority verdict 'yes' (3/5 passes agreed)]
FsF-A1-01M — F-UJI: 'Metadata contains access level and access conditions of the data' · RDA-A1-01M — metadata contains information to enable the user to get access to the data · COAR Controlled Vocabularies — Access Rights v1.0 (open / embargoed / restricted / metadata-onl
“All of Us Controlled Tier Data v7”
The All of Us Research Workbench is a controlled-access repository, serving as an institutional gatekeeper for the sensitive health data. [majority verdict 'yes' (3/5 passes agreed)]
NIH Genomic Data Sharing Policy (NOT-OD-14-124) — controlled-access via a Data Access Committee · RDA-A1.2-01D — 'Data is accessible through an access protocol that supports authentication and · NIH DMS Policy Element 5 (NOT-OD-21-014) — Access, Distribution, or Reuse Considerations (conse
No statement about when the data become available or how long they persist is present in the text.
NIH DMS Plan Element 4 (NOT-OD-21-014) — Data Preservation, Access, and Associated Timelines · NSTC Desirable Characteristics (2022), Organizational Infrastructure: 'Retention Policy' · RDA-A2-01M — 'Metadata is guaranteed to remain available after data is no longer available'
No file format is named for the released data; the text does not specify any format token.
FsF-R1.3-02D — F-UJI: 'Data is available in a file format recommended by the target research co · RDA-R1.3-02D — data is expressed in a machine-understandable community standard · RDA-I1-01D — data uses a knowledge representation expressed in a standardised format
Advisory · not in the published score
“Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) version 5.3.1 is utilized in data preparation.”
The OMOP CDM is a registered community standard for data representation (FAIRsharing). [majority verdict 'yes' (4/5 passes agreed)]
RDA-R1.3-01M — 'Metadata complies with a community standard' (priority Essential) · RDA-R1.3-01D — 'Data complies with a community standard' · RDA-I2-01M — '(Meta)data use vocabularies that follow FAIR principles'
No identifier (accession, DOI, RRID, version) for a resource other than the study's own dataset is provided; the All of Us data version string is not a standard identifier.
RDA-I3-01M — '(meta)data include references to other (meta)data' · RDA-I3-03M — 'metadata includes qualified references to other metadata' · FsF-I3-01M — F-UJI: 'Metadata includes links between the data and its related entities'
No license or terms-of-use document is named for the data; the CC BY license applies to the article only.
RDA-R1.1-01M — 'Metadata includes information about the licence under which the data can be reu · RDA-R1.1-02M — 'Metadata refers to a standard reuse licence' · RDA-R1.1-03M — 'Metadata refers to a machine-understandable reuse licence'
“Curated Data Repository version 7 C2022Q4R9”— not found in the paper; verdict downgraded
A version token (C2022Q4R9) is stated for the data used. [downgraded to 'partial' — no verifiable quote from the paper] [majority verdict 'partial' (3/5 passes agreed)]
DataCite Metadata Schema 4.6 — the 'Version' property · RDA-R1.2-01M — provenance information (which version was used is provenance) · NSTC Desirable Characteristics of Data Repositories (2022) — 'Provenance', 'Retention Policy'
“https://github.com/Su-informatics-lab/aou_acidosis”— not found in the paper; verdict downgraded
A machine-resolvable code repository URL is given. [downgraded to 'partial' — no verifiable quote from the paper]
NIH DMS Policy Element 2 (NOT-OD-21-014) — 'Related Tools, Software and/or Code' · FAIR4RS Principles v1.0 (Chue Hong et al., 2022; RDA/FORCE11/ReSA) — FAIR Principles for Resear · FORCE11 Software Citation Principles (Smith, Katz & Niemeyer, 2016, PeerJ CS 2:e86)
“R01LM013771”
An award/grant number is provided for the funding.
DataCite Metadata Schema 4.6 — 'FundingReference' property (funderName, funderIdentifier, award · Crossref Funder Registry — canonical funder identifiers for funding metadata · RDA-F2-01M — rich metadata provided to allow discovery (funding is part of the descriptive reco
Advisory · not in the published score
No specific instruments, platforms, kits, or software versions are named for the data production; the text only describes generic processes.
RDA-R1.2-01M — 'Metadata includes provenance information according to community- specific standa · FsF-R1.2-01M — F-UJI: 'Metadata includes provenance information about data creation or generati · W3C PROV-O (W3C Recommendation, 2013) — the entity/activity/agent model of provenance
“Code sets are summarized in Supplementary Material S1 (Table S1 and Figure S1: code sets and algorithm for severe/acute acidosis; Table S5: code set for metformin; Table S4: code sets for Charlson comorbidities; Table S5: code sets for SDoH; and Table S6: acidosis-related genotypes).”
Variable definitions are provided inside the article in supplementary tables, not as a separate documentation object shipped with the data. [majority verdict 'partial' (4/5 passes agreed)]
RDA-R1-01M — '(Meta)data are richly described with a plurality of accurate and relevant attribu · FsF-R1-01MD — F-UJI: 'Metadata specifies the content of the data' · NIH DMS Policy Element 3 (NOT-OD-21-014) — Standards (documentation and metadata to accompany t
Calibrated FAIR score — a parallel quality metric, independent of the DataRank citation score. See the full evaluation →
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0.0326
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: R01LM013771
National Cancer Institute
Grant: P30CA082709
National Institutes of Health
Grant: R35GM151089
National Cancer Institute
Grant: P30CA247796
National Institutes of Health
Grant: 3OT2OD023206-01S2
Communication Implementation and Coordination for NIH Precision Medicine Initiative Research Projects
National Institutes of Health
Grant: 1OT2OD025315-01
Empowerment-focused Outreach, Education and Enrollment of Tennessee Older Adults in the All of Us Research Program through Community Efforts by FiftyForward
National Institutes of Health
Grant: 1OT2OD026549-01
University of Arizona-Banner Health All of Us Research Program
National Institutes of Health
Grant: 3OT2OD023205-01S1
Communications Design and Development for NIH Precision Medicine Initiative Research Projects
National Institutes of Health
Grant: 5U24OD023163-02
Adaptive Platform for Personalized Engagement
National Institutes of Health
Grant: 5U24OD023176-04
Technology to Empower Changes in Health (TECH) Network Participant Technologies Center
National Institutes of Health
Grant: 3OT2OD026557-01S5
Illinois Precision Medicine Consortium
National Institutes of Health
Grant: 3OT2OD026556-01S2
New York City Consortium for Precision Medicine
National Institutes of Health
Grant: 3OT2OD026551-01S1
SouthEast Enrollment Center (SEEC)
National Institutes of Health
Grant: 3OT2OD025277-02S1
Healthy Americas: All of Us Research Program
National Institutes of Health
Grant: 3P30CA082709-16S3
Indiana University Melvin and Bren Simon Cancer Center Support Grant
National Institutes of Health
Grant: 3OT2OD025337-01S3
Research Matters: Creating Possibilities to Achieve Health and Wellness for All of Us Research Program
National Institutes of Health
Grant: 3OT2OD026550-01S3
Trans-America Consortium of the Health Care Systems Research Network for the All of Us Research Program
National Institutes of Health
Grant: 5R35GM151089-03
Multi-modal insights of spatially distributed cells with associations of diseases and drug response
National Institutes of Health
Grant: 3OT2OD026555-01S5
All of Us Wisconsin
National Institutes of Health
Grant: 1OT2OD026553-01
The New England Precision Medicine Consortium of the All of Us Research Program
National Institutes of Health
Grant: 5U2COD023196-04
Data and Research Support Center
National Institutes of Health
Grant: 3P30CA247796-01A1S1
UF Health Cancer Center Support Grant - Training Navigator Supplement
National Institutes of Health
Grant: 3U24OD023121-02S1
Precision Medicine Initiative Cohort Program Biobank
National Institutes of Health
Grant: 3OT2OD026554-01S2
All of Us Pennsylvania
National Institutes of Health
Grant: 3OT2OD026548-01S1
Southern All of Us Network
National Institutes of Health
Grant: 3OT2OD025276-02S7
PRIDEnet for the All of Us Research Program
National Institutes of Health
Grant: 5R01LM013771-02
Revealing Health Trajectories of Chronic Kidney Disease for Precision Medicine
NIH HHS
Grant: OT2 OD026556
NIH HHS
Grant: OT2 OD025315
NIH HHS
Grant: OT2 OD026551
NIH HHS
Grant: U24 OD023121
NIH HHS
Grant: OT2 OD026549
NIH HHS
Grant: OT2 OD025337
NIH HHS
Grant: OT2 OD025277
NIH HHS
Grant: OT2 OD026555
NIH HHS
Grant: OT2 OD026550
NIH HHS
Grant: OT2 OD026553
NIH HHS
Grant: OT2 OD023205
NIH HHS
Grant: OT2 OD026557
NIH HHS
Grant: OT2 OD026554
NIH HHS
Grant: U24 OD023163
NIH HHS
Grant: OT2 OD023206
NIH HHS
Grant: U24 OD023176
NIH HHS
Grant: OT2 OD026548
NIH HHS
Grant: U2C OD023196
NIH HHS
Grant: OT2 OD026552
NIH HHS
Grant: OT2 OD025276
Indiana University Precision Health Initiative
Indiana University Melvin
Bren Simon Comprehensive Cancer Center
University of Florida Health Cancer Center
Fields of Study
MeSH Terms
Keywords